Examkin

Infectious Diseases

502 questions

All types502Multiple choice253Matching131Ordering118
Question 121Question →

A 19-year-old male college student is brought to the emergency department by paramedics after experiencing a generalized tonic-clonic seizure that lasted 2 minutes. His roommate reports that the patient had complained of a severe headache, nausea, and high fever for the past 12 hours. His temperature is 39.6∘C39.6^\circ\text{C} (103.3∘F103.3^\circ\text{F}), blood pressure is 98/6098/60 mmHg, and heart rate is 124124/min. On physical examination, the patient is lethargic, postictal, and mildly confused. Pronounced nuchal rigidity is present. A non-blanching petechial rash is observed on his bilateral lower extremities.

Arrange the following next steps in management in the most appropriate chronological order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, immediately administer empiric intravenous antibiotics and dexamethasone, perform a non-contrast head CT scan, and finally perform a lumbar puncture.
The standard of care for suspected bacterial meningitis requires the rapid initiation of therapy. While a lumbar puncture (LP) is the definitive diagnostic test, certain patients are at high risk for cerebral herniation and require a head CT before the LP. The Infectious Diseases Society of America (IDSA) guidelines require a CT before LP in patients with immunocompromise, a history of CNS disease, new-onset seizures, papilledema, altered level of consciousness, or focal neurologic deficits. Because this patient has a new-onset seizure and altered mental status, the sequence must be: 1) Blood cultures, 2) Empiric antibiotics and dexamethasone, 3) Head CT, and 4) Lumbar puncture. This guarantees that life-saving treatment is not delayed by the time required to obtain and interpret neuroimaging.

Step-by-Step Solution

1
Recognize the clinical presentation and identify 'red flag' indications.
The patient has signs of bacterial meningitis (fever, headache, nuchal rigidity, petechial rash) along with indications for a head CT before LP (new-onset seizure and altered mental status).
Identifying red flags dictates the diagnostic and therapeutic pathway, specifically indicating the need for neuroimaging before safely accessing the subarachnoid space.
2
Determine the first immediate action upon arrival.
Obtain blood cultures.
Blood cultures are rapid and should always be drawn prior to the administration of any antimicrobials to ensure the highest yield for identifying the causative pathogen.
3
Decide the timing of empiric antimicrobial therapy.
Administer empiric intravenous antibiotics and dexamethasone immediately.
Because the patient must go to the CT scanner before the LP, definitive CSF evaluation will be delayed. To prevent mortality and neurologic deficits, empiric therapy must be given immediately after blood cultures, without waiting for the CT or LP results.
4
Determine the sequence of imaging and invasive testing.
Perform a non-contrast head CT, followed by a lumbar puncture.
The CT scan is necessary to rule out mass lesions and prevent cerebral herniation. Once mass effect is ruled out, the LP is performed to obtain CSF for definitive analysis.

Key Concept

In patients with suspected bacterial meningitis who have indications for a head CT prior to lumbar puncture (e.g., new-onset seizure, altered mental status, papilledema, immunocompromise), empiric antibiotics and dexamethasone must be administered immediately after blood cultures are drawn, before sending the patient for imaging.
Question 122Question →

A 32-year-old man is admitted to the hospital with a 1-week history of fever, chills, and profound fatigue. He has a history of intravenous drug use and was treated for a skin abscess two months ago. His temperature is 38.8°C (101.8°F), blood pressure is 110/70 mm Hg, and pulse is 108/min. Physical examination reveals a new grade 3/6 holosystolic murmur best heard at the cardiac apex. Transesophageal echocardiography demonstrates a 1.2-cm mobile vegetation on the mitral valve. Three sets of blood cultures obtained on admission grow *Enterococcus faecalis* that is susceptible to ampicillin, vancomycin, gentamicin, and linezolid. The patient is initiated on continuous intravenous ampicillin and every-8-hour intravenous gentamicin. Over the next 48 hours, his clinical symptoms improve and his temperature decreases to 37.9°C (100.2°F). However, laboratory studies show his serum creatinine has increased from 0.8 mg/dL on admission to 2.5 mg/dL, and his urine output has been 350 mL over the past 24 hours. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Discontinue gentamicin and add intravenous ceftriaxone

Answer

Discontinue gentamicin and add intravenous ceftriaxone
The most appropriate modification to this patient's regimen is to discontinue gentamicin and add intravenous ceftriaxone. This patient has *Enterococcus faecalis* infective endocarditis and has developed severe acute kidney injury (AKI) secondary to gentamicin toxicity. Enterococci are intrinsically tolerant to the bactericidal effects of cell-wall active agents (like penicillins) when used alone. To achieve the bactericidal activity required to cure endocarditis, synergistic combination therapy is necessary. The standard first-line regimens are ampicillin plus an aminoglycoside (e.g., gentamicin) or ampicillin plus ceftriaxone. Although ceftriaxone has no clinically significant activity against enterococci on its own, it saturates specific penicillin-binding proteins (PBPs, primarily PBP 2 and 3), which works synergistically with ampicillin (which binds PBP 4) to provide bactericidal activity. Because the ampicillin plus ceftriaxone regimen is equally effective as ampicillin plus gentamicin but entirely avoids aminoglycoside-associated nephrotoxicity, it is the treatment of choice for *E. faecalis* endocarditis in patients who develop AKI during therapy or those with preexisting renal dysfunction.

Step-by-Step Solution

1
Identify the patient's primary diagnosis and current clinical status.
The patient has Enterococcus faecalis infective endocarditis and has developed oliguric acute kidney injury (AKI) while receiving ampicillin and gentamicin.
Establishing the current complication is necessary to determine the appropriate next step in management.
2
Evaluate the current antimicrobial regimen's role in the patient's complication.
Gentamicin is a well-known nephrotoxic agent and is the most likely cause of the acute kidney injury.
Identifying the offending agent allows for targeted modification of the regimen.
3
Determine the optimal alternative therapy that maintains efficacy while avoiding further toxicity.
Substituting ceftriaxone for gentamicin provides the necessary bactericidal synergy against E. faecalis without causing further nephrotoxicity.
Endocarditis requires bactericidal therapy, and the ampicillin-ceftriaxone combination achieves this synergy through complementary binding of penicillin-binding proteins.

Key Concept

Management of Enterococcus faecalis infective endocarditis in the setting of aminoglycoside-induced acute kidney injury.
Question 123Question →

Match each clinical vignette describing a systemic fungal infection with the most appropriate first-line pharmacotherapy.

Click a left item, then click its matching right item

Items

A 45-year-old immunocompetent man from Wisconsin with a 6-week history of productive cough, low-grade fever, and a verrucous, crusted plaque on his forearm. Sputum cytology reveals large, broad-based budding yeasts. He is hemodynamically stable with no neurologic symptoms.
A 32-year-old man with advanced HIV presents with a 4-week history of fever, significant weight loss, hepatosplenomegaly, and painful palatal ulcers. Bone marrow biopsy demonstrates small oval yeasts packed closely within macrophages.
A 38-year-old woman with advanced HIV presents with a 2-week history of worsening headache, nausea, and lethargy. Lumbar puncture reveals an opening pressure of 320 mm H2O. CSF India ink preparation reveals heavily encapsulated budding yeasts.
A 55-year-old man with acute myeloid leukemia and profound neutropenia for 15 days develops fever, pleuritic chest pain, and hemoptysis. Chest computed tomography shows a right upper lobe macronodule surrounded by a ground-glass opacity (halo sign).

Matches

Show answer & explanation

Answer

Mild-to-moderate blastomycosis is matched with oral itraconazole; Disseminated histoplasmosis is matched with intravenous liposomal amphotericin B followed by oral itraconazole; Cryptococcal meningoencephalitis is matched with intravenous liposomal amphotericin B plus oral flucytosine; Invasive pulmonary aspergillosis is matched with intravenous voriconazole.
Each fungal infection dictates a highly specific regimen. Mild blastomycosis is successfully treated with itraconazole. Disseminated histoplasmosis demands amphotericin B induction followed by itraconazole maintenance. Cryptococcal meningitis requires synergistic amphotericin B and flucytosine to clear the CNS. Invasive aspergillosis uniquely requires the mold-active triazole voriconazole.

Step-by-Step Solution

1
Analyze the first vignette to determine the pathogen and disease severity.
Broad-based budding yeasts in a stable patient from Wisconsin indicates mild-to-moderate blastomycosis, which responds well to oral triazoles.
Accurate pathogen identification and severity stratification dictate whether oral or intravenous antifungal therapy is required.
2
Analyze the second vignette for pathogen morphology and clinical status.
Intracellular yeasts in macrophages with hepatosplenomegaly in an HIV patient indicates progressive disseminated histoplasmosis, requiring aggressive two-step therapy.
Disseminated endemic mycoses in severely immunocompromised hosts are fatal without rapid, broad fungicidal induction.
3
Evaluate the third vignette based on CSF findings.
Encapsulated yeasts in CSF with high opening pressure indicates cryptococcal meningitis, necessitating combination therapy that penetrates the blood-brain barrier.
CNS fungal infections require specific regimens optimized for rapid CSF sterilization to prevent mortality.
4
Interpret the fourth vignette's radiologic and hematologic clues.
A prolonged neutropenic patient with hemoptysis and a CT halo sign has invasive pulmonary aspergillosis, requiring targeted mold-active therapy.
Aspergillus is an angioinvasive mold; its treatment fundamentally differs from yeast infections.

Key Concept

Definitive Pharmacotherapy for Systemic Fungal Infections based on Pathogen and Disease Severity
Question 124Question →

A physician evaluates a 68-year-old woman who is currently on hospital day 3 for the treatment of urosepsis. Upon admission to the intensive care unit three days ago, the patient was hypotensive and febrile. She received aggressive fluid resuscitation and was empirically started on intravenous vancomycin and cefepime. She was transferred to the general medical ward yesterday. Today, her vital signs are stable, she has been afebrile for 24 hours, and she is comfortably eating a regular diet. Initial blood and urine cultures now show growth of *Escherichia coli*. Antimicrobial susceptibility testing reveals the isolate is sensitive to ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole, but resistant to ampicillin. Which of the following is the most appropriate next step in antibiotic therapy?

Show answer & explanation

Answer: Transition to oral trimethoprim-sulfamethoxazole

Answer

Transition to oral trimethoprim-sulfamethoxazole
The correct answer is to transition the patient to oral trimethoprim-sulfamethoxazole. Antimicrobial stewardship principles dictate two major changes in this scenario: de-escalation and IV-to-PO transition. First, once a patient with a severe bacterial infection (such as urosepsis) is clinically stable, afebrile, and able to take oral medications, they should be transitioned from intravenous to highly bioavailable oral antibiotics. Trimethoprim-sulfamethoxazole has excellent oral bioavailability and achieves high concentrations in both the serum and urinary tract. Second, broad-spectrum empiric therapy (vancomycin and cefepime) must be de-escalated to targeted, narrow-spectrum therapy based on definitive culture and susceptibility results. Since the isolated E. coli is susceptible to trimethoprim-sulfamethoxazole, stepping down to this targeted oral agent is the most appropriate management.

Step-by-Step Solution

1
Assess the patient's current clinical stability and route of administration feasibility.
The patient is hemodynamically stable, has been afebrile for 24 hours, and is successfully tolerating a regular diet.
Patients with severe infections who have clinically improved and can absorb oral medications are excellent candidates for an intravenous-to-oral (IV-to-PO) transition.
2
Evaluate the microbiological data and susceptibility results.
Cultures isolated Escherichia coli that is susceptible to ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole.
Empiric broad-spectrum therapy must be de-escalated to targeted, narrow-spectrum therapy once susceptibilities are known to prevent resistance and reduce adverse effects.
3
Select the most appropriate definitive therapy.
Oral trimethoprim-sulfamethoxazole is chosen as the next step.
It provides targeted, narrow-spectrum coverage for the susceptible E. coli isolate, has excellent oral bioavailability for completing the treatment course, and avoids unnecessary intravenous access.

Key Concept

Antibiotic Stewardship: Intravenous to Oral Transition and De-escalation
Question 125Question →

A 42-year-old man presents to the urgent care clinic with a 2-day history of increasing redness, swelling, and pain on his right lower leg. He denies fevers, chills, or recent trauma, though he reports chronic itching between his toes. He has no significant past medical history and takes no medications. His temperature is 37.0°C (98.6°F), blood pressure is 118/76 mmHg, pulse is 72/min, and respiratory rate is 14/min. Physical examination of the right lower extremity reveals a warm, tender, and erythematous plaque with indistinct borders extending from the ankle to the mid-calf. There is no purulent exudate, ulceration, or fluctuance. Examination of the feet shows fissuring and maceration between the fourth and fifth digits. Which of the following is the most appropriate empiric treatment for this patient?

Show answer & explanation

Answer: Oral cephalexin

Answer

Oral cephalexin is the most appropriate initial therapy for this patient.
This patient presents with mild, uncomplicated, non-purulent cellulitis, as evidenced by a spreading area of warm, tender erythema without exudate or fluctuance. The fissuring from tinea pedis likely served as the portal of entry for bacteria. Non-purulent cellulitis is primarily caused by beta-hemolytic streptococci (most notably Group A Streptococcus) and, less commonly, methicillin-susceptible Staphylococcus aureus (MSSA). Because the patient is hemodynamically stable and lacks systemic signs of infection (e.g., fever, tachycardia), outpatient oral therapy is appropriate. Good antibiotic stewardship dictates using the narrowest spectrum agent effective against the likely pathogens. An oral first-generation cephalosporin (such as cephalexin) or a penicillinase-resistant penicillin (such as dicloxacillin) is the gold standard empiric therapy for this condition.

Step-by-Step Solution

1
Identify the clinical syndrome.
The patient has unilateral erythema, warmth, and swelling without fluctuance or purulence.
These findings are classic for mild, non-purulent cellulitis. The tinea pedis provides a portal of entry for skin flora.
2
Determine the most likely causative organisms.
Beta-hemolytic streptococci (e.g., Group A Streptococcus) and methicillin-susceptible Staphylococcus aureus (MSSA).
Non-purulent cellulitis is overwhelmingly caused by streptococci, whereas purulent cellulitis (with abscess or exudate) is more frequently caused by Staphylococcus aureus (including MRSA).
3
Select the appropriate pharmacotherapy based on antibiotic stewardship principles.
A narrow-spectrum oral beta-lactam such as cephalexin, penicillin, or dicloxacillin.
The patient is hemodynamically stable, has no signs of systemic toxicity, and lacks risk factors for MRSA. Broad-spectrum or intravenous antibiotics are unnecessary and inappropriate.

Key Concept

Empiric treatment for mild, non-purulent cellulitis should target beta-hemolytic streptococci and MSSA using narrow-spectrum oral agents like cephalexin.
Question 126Question →

Match each clinical exposure scenario with the most appropriate post-exposure prophylaxis or management strategy.

Click a left item, then click its matching right item

Items

A 40-year-old man in an endemic area who presents to the clinic after safely removing an engorged Ixodes scapularis tick that was attached to his abdomen for approximately 48 hours.
A 28-year-old pregnant woman, with no prior history of varicella infection or vaccination, who had significant face-to-face contact with a child with active chickenpox 2 days ago.
A 32-year-old unvaccinated medical resident who sustains a deep needlestick injury from a patient known to be hepatitis B surface antigen (HBsAg) positive.
A 14-year-old boy who sustains a provoked bite on the hand from a vaccinated, healthy-appearing neighborhood dog that is available for quarantine.

Matches

Show answer & explanation

Answer

The tick bite meets criteria for single-dose doxycycline. The pregnant woman exposed to varicella requires VZIG. The unvaccinated healthcare worker exposed to HBV requires both HBIG and the HBV vaccine series. The provoked bite from a healthy domestic dog requires wound care and 10-day observation of the animal.
Each clinical scenario presents a distinct infectious exposure requiring a targeted preventive strategy. Tick bites meeting specific attachment criteria require single-dose doxycycline. Pregnant patients exposed to varicella require passive immunity with VZIG because live vaccines are contraindicated. Unvaccinated healthcare workers exposed to Hepatitis B require both active and passive immunity. Bites from healthy domestic animals available for quarantine do not require immediate rabies PEP, only observation and wound care.

Step-by-Step Solution

1
Analyze the tick bite exposure in the 40-year-old man.
The patient meets criteria for prophylaxis: Ixodes tick, endemic area, attachment time >36 hours (48 hours).
Single-dose oral doxycycline is highly effective at preventing Lyme disease when administered under these specific criteria.
2
Evaluate the varicella exposure in the pregnant patient.
The patient lacks immunity and faces a high-risk exposure, but live vaccines are contraindicated.
Varicella-zoster immune globulin (VZIG) provides immediate, safe passive immunity for pregnant individuals to prevent congenital and maternal complications.
3
Assess the needlestick injury in the medical resident.
An unvaccinated host was exposed to a known HBsAg-positive source.
Optimal prevention of Hepatitis B infection requires immediate passive immunity via HBIG and the initiation of long-lasting active immunity via the HBV vaccination series.
4
Determine the rabies risk for the dog bite.
The dog is a domestic animal, healthy-appearing, and available for quarantine.
Immediate rabies PEP is unnecessary; observing the dog for 10 days ensures it was not shedding the rabies virus at the time of the bite.

Key Concept

Appropriate selection of post-exposure prophylaxis based on pathogen, host immune status, and exposure characteristics.
Question 127Question →

Match each clinical exposure scenario with its most appropriate post-exposure prophylaxis or targeted management regimen.

Click a left item, then click its matching right item

Items

A 19-year-old student who shared a small dormitory room with a peer recently diagnosed with meningococcal meningitis.
A 32-year-old nurse who sustained a deep percutaneous injury with a hollow-bore needle used on a patient with uncontrolled HIV.
A 45-year-old man who woke up to find a live bat flying in his bedroom, though no visible bite marks or scratches are identified.
A 27-year-old asymptomatic medical resident with a newly positive interferon-gamma release assay (IGRA) and a clear chest radiograph.

Matches

Show answer & explanation

Answer

The correct pairings match meningococcal exposure to targeted antibiotic chemoprophylaxis, HIV needlestick to 3-drug antiretroviral therapy, bat exposure to rabies immune globulin and vaccine, and latent tuberculosis to a rifamycin-based or isoniazid-based regimen.
Each clinical exposure mandates a specific, evidence-based prophylactic intervention designed to either eradicate colonization, neutralize viral entry, or prevent the reactivation of a latent infection. The pairings correctly reflect current CDC and professional society guidelines for infectious disease post-exposure management.

Step-by-Step Solution

1
Analyze the infectious exposure in each clinical scenario.
Identified exposures to Neisseria meningitidis, HIV, Rabies virus, and Mycobacterium tuberculosis.
Different pathogens have distinct incubation periods, transmission mechanisms, and pathogenesis that dictate the type of prophylaxis required.
2
Determine the risk level and the goal of management for each exposure.
Determined that all four scenarios meet the threshold for intervention to prevent severe active disease.
Risk stratification ensures that interventions are applied appropriately according to evidence-based guidelines without promoting antimicrobial resistance.
3
Select the guideline-recommended post-exposure prophylaxis or targeted treatment for each identified pathogen.
Matched each exposure to its specific pharmacologic regimen.
Ensures the selected regimens provide the appropriate mechanism of action (e.g., viral suppression, toxin neutralization, or bacterial eradication) for the suspected pathogen.

Key Concept

Evidence-based post-exposure prophylaxis and management of latent infections
Question 128Question →

Match each healthcare worker's specific post-exposure scenario with the most appropriate Hepatitis B virus (HBV) management protocol according to current CDC guidelines.

Click a left item, then click its matching right item

Items

An unvaccinated medical student sustains a deep needlestick injury while drawing blood from a patient who is known to be HBsAg-positive.
A resident physician who is a documented vaccine non-responder (anti-HBs < 10 mIU/mL after two complete vaccination series) is exposed to HBsAg-positive blood.
A nurse who completed the vaccination series 5 years ago, but never had post-vaccination serologic testing, sustains a needlestick injury from an HBsAg-positive patient.
A fully vaccinated attending physician with a documented anti-HBs titer of 45 mIU/mL (measured three years ago) is splashed in the eye with blood from an HBsAg-positive patient.
A hospital janitor with no prior Hepatitis B vaccination history sustains a skin puncture from a discarded needle; the source patient is identified and tests HBsAg-negative.

Matches

Show answer & explanation

Answer

The correct matches correctly apply the CDC Hepatitis B post-exposure prophylaxis (PEP) algorithm based on the exposed healthcare worker's specific vaccination status, previous immunologic response to the vaccine, and the source patient's confirmed HBsAg status.
The correct matches strictly adhere to the CDC guidelines for Hepatitis B virus (HBV) post-exposure prophylaxis in healthcare settings. The protocol depends on the interaction between the source patient's HBsAg status and the healthcare worker's vaccination/immune status. Passive immunization (HBIG) provides immediate, short-term protection and is reserved for susceptible individuals exposed to HBsAg-positive blood. Active immunization (vaccine) establishes long-term protection and is given to those who are unvaccinated or need a booster. Known responders require no intervention, whereas known non-responders to two series require double passive prophylaxis.

Step-by-Step Solution

1
Determine the source patient's Hepatitis B surface antigen (HBsAg) status.
The source is either HBsAg-positive, HBsAg-negative, or unknown.
Hepatitis B immune globulin (HBIG) is only potentially indicated if the source is HBsAg-positive or high-risk unknown. If the source is definitively negative, passive immunization is never required.
2
Determine the exposed healthcare worker's previous Hepatitis B vaccination status.
The HCW is classified as unvaccinated, previously vaccinated with unknown response, known responder, or known non-responder.
The healthcare worker's existing immune status dictates whether they need passive immunity (HBIG), active immunity (vaccine), both, or neither.
3
Match the specific combination of source status and HCW immune status to the established algorithm.
Unvaccinated + Positive = HBIG + Vaccine; Non-responder + Positive = HBIG x 2; Unknown response + Positive = Test titer and treat if low; Known responder + Positive = No PEP; Unvaccinated + Negative = Vaccine only.
Precise application of the algorithm prevents unnecessary HBIG administration while ensuring maximum protection against occupational HBV transmission.

Key Concept

Hepatitis B Virus (HBV) Occupational Post-Exposure Prophylaxis Algorithm
Question 129Question →

Match each patient's clinical presentation and unique host factors with the most appropriate empiric or targeted pharmacotherapy.

Click a left item, then click its matching right item

Items

A 67-year-old man with altered mental status, fever, and nuchal rigidity. He has a documented history of severe, IgE-mediated anaphylaxis to penicillin.
A 28-year-old woman at 16 weeks gestation presenting with a slowly expanding, 8-cm annular erythematous rash with central clearing on her thigh after a camping trip.
A 42-year-old man with advanced HIV (CD4 count 35 cells/mm³) presenting with severe odynophagia. Endoscopy reveals large, deep, linear ulcerations in the mid-to-distal esophagus.
A 72-year-old woman in a skilled nursing facility who develops frequent, watery, foul-smelling diarrhea and a leukocyte count of 22,000/mm³ following a recent course of clindamycin.
A 35-year-old man from Ohio presenting with a 3-week history of fever and cough. Transbronchial biopsy reveals narrow-based budding yeasts within macrophages.

Matches

Show answer & explanation

Answer

The correct matches align specific host factors (such as pregnancy, severe allergies, or immunosuppression) and characteristic clinical presentations with their guideline-directed antimicrobial therapies.
Each correct pairing synthesizes the diagnostic clues of a specific infectious disease with current treatment guidelines, adjusting for critical host modifiers like pregnancy and allergies.

Step-by-Step Solution

1
Analyze the vignette to identify the underlying pathogen or clinical syndrome.
Identified syndromes: Bacterial meningitis, Lyme disease, CMV esophagitis, Clostridioides difficile colitis, and Histoplasmosis.
Pathogen identification dictates the spectrum of antimicrobial activity required.
2
Identify modifying host factors in each vignette.
Modifiers found: Age >50 + severe IgE penicillin allergy (meningitis), pregnancy (Lyme), advanced HIV (esophagitis), age + prior antibiotics (C. difficile).
Host factors dictate necessary changes to first-line regimens (e.g., avoiding cephalosporins in anaphylaxis, avoiding teratogens).
3
Select the appropriate targeted or empiric regimen.
Matched each presentation to its safest and most effective pharmacotherapy.
Ensures adherence to antibiotic stewardship and current clinical guidelines.

Key Concept

Tailoring antimicrobial therapy requires integrating pathogen suspicion with critical host factors such as age, immune status, pregnancy, and drug allergies.
Question 130Question →

An 82-year-old female resident of a skilled nursing facility presents for a routine wellness examination. The nursing staff reports that her urine has appeared cloudy and foul-smelling over the past three days. However, the patient denies any dysuria, urinary frequency, urinary urgency, flank pain, or changes in her cognitive baseline. Her temperature is 37.0°C (98.6°F), blood pressure is 128/78 mm Hg, and pulse is 72/min. Physical examination reveals a soft, non-tender abdomen without suprapubic or costovertebral angle tenderness. A clean-catch urinalysis reveals positive leukocyte esterase, positive nitrites, and 45 leukocytes/hpf. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Observation without antibiotic therapy

Answer

Observation without antibiotic therapy
The correct management for this patient is observation without antibiotic therapy. She has asymptomatic bacteriuria (ASB), which is defined as the presence of bacteria in the urine without typical signs or symptoms of a urinary tract infection (e.g., dysuria, urgency, frequency, suprapubic pain, or fever). ASB is highly prevalent among elderly patients, especially those in long-term care facilities. Cloudy or foul-smelling urine is often reported by caregivers but is not a reliable indicator of symptomatic infection and should not independently prompt treatment. According to infectious disease guidelines, ASB should not be screened for or treated except in specific populations (e.g., pregnant women, patients undergoing invasive urologic procedures). Treating ASB in this demographic does not prevent future symptomatic urinary tract infections or improve mortality; instead, it violates antibiotic stewardship by increasing the risk of multi-drug resistant organisms, adverse drug effects, and Clostridioides difficile infections.

Step-by-Step Solution

1
Evaluate the patient's symptoms in the context of the urinalysis findings.
The patient has abnormal urinalysis findings (pyuria, bacteriuria) but completely lacks clinical symptoms of a urinary tract infection (no dysuria, frequency, fever, or confusion).
Differentiating between asymptomatic bacteriuria and a symptomatic urinary tract infection is the critical branch point for deciding whether antimicrobial therapy is necessary.
2
Determine the appropriate management based on current infectious disease guidelines.
The diagnosis is asymptomatic bacteriuria, which should be managed with observation rather than antibiotics.
Treating asymptomatic bacteriuria does not improve clinical outcomes and increases the risk of adverse drug reactions, antibiotic resistance, and Clostridioides difficile infection.

Key Concept

Management of Asymptomatic Bacteriuria
Question 131Question →

Following a week-long camping excursion in Rhode Island, a 34-year-old woman presents to an urgent care clinic with a 4-day history of sudden-onset high fever, profound fatigue, severe headache, and diffuse muscle pain. She has no significant past medical history and takes no medications. Her temperature is 38.9°C (102°F), blood pressure is 112/72 mmHg, and pulse is 98/min. Physical examination reveals no skin rashes, eschars, lymphadenopathy, or joint swelling. Sclerae are anicteric. Laboratory evaluation shows:

TestResult
Hemoglobin13.5 g/dL
Leukocyte count2,400/mm³
Platelet count78,000/mm³
Total bilirubin0.9 mg/dL
Aspartate aminotransferase (AST)115 U/L
Alanine aminotransferase (ALT)108 U/L

A peripheral blood smear is examined and reveals no intraerythrocytic inclusions. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate oral doxycycline therapy

Answer

Initiate oral doxycycline therapy
The clinical presentation of acute fever, headache, and myalgias in a patient returning from a highly endemic area, combined with the classic laboratory triad of leukopenia, thrombocytopenia, and elevated transaminases, is highly suspicious for human granulocytic anaplasmosis. The absence of a rash makes Lyme disease less likely, and the absence of hemolytic anemia (normal hemoglobin and bilirubin) alongside a negative peripheral blood smear (no Maltese crosses or intraerythrocytic rings) effectively rules out babesiosis. Because anaplasmosis can progress to severe complications such as respiratory failure or toxic shock-like syndrome, empiric therapy with doxycycline must be initiated immediately upon clinical suspicion. Confirmatory testing (e.g., PCR or serology) should be ordered, but treatment must never be delayed while waiting for the results.

Step-by-Step Solution

1
Analyze the patient's exposure history and clinical presentation.
The patient has a history of tick exposure in an endemic area (Rhode Island) presenting with an acute febrile illness, severe myalgias, and headache without a rash.
Identifying the geographic and clinical context narrows the differential diagnosis to tick-borne illnesses such as Lyme disease, anaplasmosis, and babesiosis.
2
Evaluate the laboratory findings to differentiate between the potential tick-borne pathogens.
Labs show the classic triad of leukopenia, thrombocytopenia, and elevated transaminases. The absence of anemia, normal bilirubin, and negative blood smear make babesiosis highly unlikely.
This specific laboratory triad is the hallmark of human granulocytic anaplasmosis, caused by Anaplasma phagocytophilum.
3
Determine the most appropriate management based on the suspected diagnosis.
Empiric oral doxycycline is selected as the optimal initial step.
Anaplasmosis can cause severe complications if untreated. Therapy with doxycycline must be started based on clinical suspicion and not delayed for confirmatory testing.

Key Concept

Clinical presentation and empiric management of human granulocytic anaplasmosis
Question 132Question →

During morning rounds in the surgical intensive care unit, a physician reviews the microbiological data for a patient recovering from an emergency laparotomy. The patient, a 67-year-old female, underwent surgery six days prior for perforated diverticulitis. At that time, she presented in septic shock and was resuscitated with intravenous fluids, vasopressors, and empiric broad-spectrum coverage utilizing vancomycin and piperacillin-tazobactam. Her clinical status has steadily improved; she was extubated on postoperative day 3 and is currently hemodynamically stable without vasoactive medications. Current vital signs show a temperature of 37.8°C (100.0°F). The electronic medical record flags a new critical result: blood cultures drawn 48 hours ago demonstrate growth of *Enterobacter cloacae*. The laboratory reports the isolate is susceptible to ceftriaxone, ceftazidime, cefepime, piperacillin-tazobactam, and meropenem. It shows resistance to ampicillin and first-generation cephalosporins. Based on these findings, which of the following is the most appropriate modification to her pharmacotherapy?

Show answer & explanation

Answer: Switch the regimen to intravenous cefepime only

Answer

Switch the regimen to intravenous cefepime only.
The most appropriate action is to switch the regimen to intravenous cefepime only. The patient has a bloodstream infection caused by *Enterobacter cloacae*. This organism, along with *Klebsiella aerogenes* and *Citrobacter freundii*, typically harbors a chromosomal gene for AmpC beta-lactamase. While these organisms often test susceptible to third-generation cephalosporins (like ceftriaxone) *in vitro*, these antibiotics act as strong inducers of the AmpC enzyme and are susceptible to hydrolysis by it. Using them in vivo for a high-inoculum or serious infection (like bacteremia) frequently results in the rapid selection of derepressed mutants and subsequent treatment failure. Cefepime, a fourth-generation cephalosporin, is a weak inducer of AmpC and is highly stable against hydrolysis by the enzyme, making it the drug of choice. Vancomycin can be safely discontinued because the causative pathogen has been fully identified as a Gram-negative bacillus.

Step-by-Step Solution

1
Evaluate the microbiology results.
Blood cultures are positive for Enterobacter cloacae, a Gram-negative bacillus known to harbor an inducible chromosomal AmpC beta-lactamase.
Identifying the specific pathogen allows for targeted antimicrobial therapy.
2
Analyze the resistance profile and implications for therapy.
Although ceftriaxone and piperacillin-tazobactam appear susceptible in vitro, they are highly associated with clinical failure in serious AmpC infections due to enzyme induction or weak inhibition.
In vitro susceptibility does not always equal in vivo clinical success, especially for AmpC-producing organisms.
3
Select the most appropriate targeted agent.
Cefepime is selected because it is a weak inducer of AmpC and is stable against hydrolysis. Vancomycin is discontinued as there is no Gram-positive pathogen.
Cefepime provides definitive efficacy while practicing good antimicrobial stewardship by sparing carbapenems.

Key Concept

Treatment of serious infections caused by organisms with inducible AmpC beta-lactamases (e.g., Enterobacter, Klebsiella aerogenes, Citrobacter freundii) requires agents that are weak inducers and stable against hydrolysis, such as cefepime or carbapenems. Third-generation cephalosporins should be avoided despite apparent in vitro susceptibility.
Estimated Time:1m 15s
Question 133Question →

A 39-year-old man is evaluated in the hospital on hospital day 3. He was admitted for community-acquired pneumonia after presenting with a high fever, productive cough, and right lower lobe consolidation on chest radiography. On admission, he was empirically started on intravenous ceftriaxone and oral azithromycin. Over the past 48 hours, his fever has resolved, his respiratory symptoms have significantly improved, and he is eating a regular diet. His temperature is 37.1 C (98.8 F), blood pressure is 124/82 mm Hg, pulse is 76/min, and respiratory rate is 14/min. Sputum and blood cultures obtained on admission both grow Streptococcus pneumoniae. Antimicrobial susceptibility testing reveals the isolate is susceptible to amoxicillin, ceftriaxone, levofloxacin, and linezolid. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Transition to oral amoxicillin

Answer

Transition to oral amoxicillin
The correct action is to transition the patient to oral amoxicillin. This patient was admitted with community-acquired pneumonia and appropriately started on empiric broad-spectrum therapy (ceftriaxone and azithromycin). After 3 days, he is clinically stable, afebrile, and tolerating an oral diet, satisfying all standard criteria for IV-to-PO step-down therapy. Furthermore, cultures have returned positive for Streptococcus pneumoniae that is susceptible to amoxicillin. According to the core principles of antimicrobial stewardship, once a pathogen is identified and susceptibilities are known, empiric therapy should be immediately de-escalated to the narrowest effective, targeted agent. Oral amoxicillin is the ideal narrow-spectrum choice for susceptible S. pneumoniae.

Step-by-Step Solution

1
Assess the patient's clinical trajectory and criteria for intravenous to oral (IV-to-PO) transition.
The patient is afebrile for 48 hours, hemodynamically stable, showing clinical improvement, and tolerating oral intake.
Meeting these criteria indicates the patient can safely be transitioned from intravenous to oral antibiotics.
2
Evaluate the microbiology results and susceptibility data.
Cultures definitively identified Streptococcus pneumoniae, which is susceptible to narrow-spectrum beta-lactams (amoxicillin, ceftriaxone) as well as broader agents.
Identifying the specific pathogen allows for de-escalation from empiric broad-spectrum therapy to targeted therapy.
3
Select the most appropriate targeted oral agent based on antibiotic stewardship principles.
Oral amoxicillin is selected as the definitive therapy.
Amoxicillin provides excellent coverage for susceptible S. pneumoniae with the narrowest possible spectrum, minimizing collateral damage to the patient's microbiome and reducing the risk of resistant organisms.

Key Concept

Antibiotic Stewardship: De-escalation of Therapy
Estimated Time:1m 0s
Question 134Question →

A 62-year-old female presents to the emergency room accompanied by her daughter, who reports that her mother has been increasingly confused and feverish over the preceding 24 hours. Her past medical history is notable for a deceased-donor renal transplant performed three years ago, maintained on a regimen of tacrolimus and mycophenolate mofetil. Vital signs show a temperature of 39.4°C (102.9°F), blood pressure of 110/65 mm Hg, pulse of 112/min, and respirations of 20/min. Physical examination reveals marked nuchal rigidity and a positive Kernig sign. The patient is somnolent but arousable to verbal stimuli. There are no focal motor deficits, but fundoscopic examination is deferred due to poor patient cooperation. The clinical team suspects acute bacterial meningitis and prepares to initiate the management protocol. Arrange the following critical next steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Obtain blood cultures, administer empiric antibiotics and dexamethasone, perform a CT scan of the head, and finally perform a lumbar puncture.
The correct sequence for managing suspected bacterial meningitis in a patient with indications for neuroimaging prior to lumbar puncture begins with obtaining blood cultures. Indications for a CT scan before lumbar puncture include an immunocompromised state, history of central nervous system disease, new-onset seizure, papilledema, focal neurologic deficit, or altered mental status. Because the CT scan will delay the lumbar puncture, immediate administration of empiric antibiotics (including ampicillin for Listeria coverage in an immunocompromised host) and adjunctive dexamethasone follows. A noncontrast CT of the head is then performed to rule out mass effect, and if safe, the lumbar puncture is performed last.

Step-by-Step Solution

1
Identify indications for neuroimaging prior to lumbar puncture.
The patient has an immunocompromised state (renal transplant) and altered mental status (somnolence), both of which mandate a CT scan of the head before performing a lumbar puncture.
Performing a lumbar puncture in the presence of a space-occupying lesion can lead to fatal cerebral herniation.
2
Determine the impact of the required CT scan on treatment timing.
Because the CT scan will delay the lumbar puncture, empiric therapy must be given beforehand.
Delaying antimicrobial therapy in bacterial meningitis significantly increases mortality and neurologic morbidity.
3
Sequence the interventions appropriately based on diagnostic yield and therapeutic urgency.
Blood cultures are drawn first, immediately followed by empiric antibiotics and dexamethasone, then the CT scan, and finally the lumbar puncture.
Blood cultures should be drawn before antibiotics sterilize the blood, but antibiotics must be given before the patient leaves for the CT scanner.

Key Concept

Management sequence for suspected bacterial meningitis with high-risk features requiring neuroimaging prior to lumbar puncture.
Question 135Question →

A 28-year-old man presents to a primary care clinic requesting an HIV test. He reports having unprotected receptive anal intercourse with a new male partner two months ago. He currently has no symptoms, and his physical examination is unremarkable. Arrange the following steps in the most appropriate chronological sequence for the diagnosis and initial management of this patient, assuming all subsequent tests confirm the presence of HIV.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first screen with a fourth-generation HIV-1/2 antigen/antibody combination immunoassay, followed by an HIV-1/HIV-2 antibody differentiation immunoassay for confirmation. Once confirmed, baseline labs (CD4 count, viral load, and genotypic resistance testing) must be drawn before finally initiating daily oral antiretroviral therapy.
The standard CDC algorithm for HIV diagnosis begins with a highly sensitive fourth-generation antigen/antibody combination immunoassay. A positive result is followed by an HIV-1/HIV-2 antibody differentiation immunoassay for confirmation and typing. Following confirmation, the standard of care is 'rapid ART', meaning antiretroviral therapy is started as soon as possible (often the same day). However, it is critical to obtain blood for baseline CD4 count, viral load, and genotypic resistance testing before administering the first dose of ART, as the medications will rapidly suppress viremia and obscure baseline resistance patterns.

Step-by-Step Solution

1
Select the initial screening test.
Perform a fourth-generation HIV-1/2 antigen/antibody combination immunoassay.
This is the most sensitive initial test because it detects both HIV antibodies and the p24 antigen, which appears earlier in the course of infection than antibodies.
2
Confirm the diagnosis.
Perform an HIV-1/HIV-2 antibody differentiation immunoassay.
A positive screening test must be confirmed with a highly specific differentiation assay to rule out false positives and determine if the patient has HIV-1 or HIV-2.
3
Obtain baseline laboratory evaluations.
Obtain blood samples for CD4 cell count, HIV RNA viral load, and genotypic resistance testing.
These labs are essential for staging the disease and guiding long-term therapy. They must be drawn before ART is started, as ART will rapidly suppress the viral load and mask baseline resistance mutations.
4
Start treatment.
Initiate daily oral antiretroviral therapy (ART).
Rapid initiation of ART improves patient outcomes and reduces the risk of transmission. Treatment should be started immediately after baseline labs are drawn, even before resistance testing results are available.

Key Concept

The diagnostic algorithm for HIV involves initial screening with a 4th-generation antigen/antibody assay, followed by a confirmatory differentiation assay. Once confirmed, baseline labs (CD4, viral load, resistance testing) are drawn immediately prior to starting rapid antiretroviral therapy.
Estimated Time:1m 30s
Question 136Question →

Match each clinical presentation with its most appropriate first-line antimicrobial therapy.

Click a left item, then click its matching right item

Items

A 24-year-old man presents with a solitary, painless, indurated ulcer on his glans penis. Dark-field microscopy of the exudate shows motile spirochetes.
A 30-year-old woman presents with a slowly expanding, flat, erythematous rash with central clearing on her thigh, one week after a camping trip.
A 21-year-old man presents with dysuria and purulent urethral discharge. Gram stain reveals neutrophils and intracellular Gram-negative diplococci.
A 45-year-old man presents with a painful, fluctuant skin abscess on his lower leg. He requires oral antibiotics covering community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).

Matches

Show answer & explanation

Answer

Primary syphilis matches with benzathine penicillin G; early Lyme disease matches with doxycycline; gonococcal urethritis matches with ceftriaxone; and CA-MRSA skin infection matches with trimethoprim-sulfamethoxazole.
Each clinical scenario presents a classic presentation of a common outpatient infection. The pairings reflect the standard-of-care first-line antimicrobial therapies for these specific pathogens, adhering to current clinical guidelines and antibiotic stewardship principles.

Step-by-Step Solution

1
Diagnose the underlying infectious syndrome for each clinical vignette.
Patient 1 has primary syphilis, Patient 2 has early localized Lyme disease, Patient 3 has gonococcal urethritis, and Patient 4 has a CA-MRSA skin abscess.
Accurate pathogen identification or syndrome recognition is required for appropriate antimicrobial selection.
2
Select the guideline-recommended first-line therapy for each diagnosis.
Syphilis requires benzathine penicillin G. Lyme disease requires doxycycline. Gonorrhea requires ceftriaxone. CA-MRSA requires an agent like trimethoprim-sulfamethoxazole.
Following established treatment guidelines ensures maximum efficacy and supports antibiotic stewardship.

Key Concept

Empiric and targeted antimicrobial therapy for common outpatient infectious diseases.
Estimated Time:1m 30s
Question 137Question →

During morning rounds on the medical ward, a physician reviews the progress of a 72-year-old male patient. The patient was admitted 72 hours ago due to fever and acute delirium secondary to a catheter-associated urinary tract infection. Upon admission, the urinary catheter was removed, and broad-spectrum empiric therapy with intravenous vancomycin and piperacillin-tazobactam was initiated. Currently, the patient is afebrile, hemodynamically stable, and eating a regular diet. His mental status has completely returned to baseline. Final culture results from both blood and urine reveal growth of *Enterococcus faecalis*. Susceptibility panels indicate the organism is sensitive to ampicillin, vancomycin, linezolid, and daptomycin. Based on the culture results and clinical improvement, which of the following is the most appropriate pharmacological intervention for this patient?

Show answer & explanation

Answer: Transition to oral amoxicillin

Answer

Transition to oral amoxicillin
The most appropriate next step is to transition the patient to oral amoxicillin. This patient has a catheter-associated urinary tract infection with secondary bacteremia that has clinically resolved following appropriate source control (catheter removal) and initial empiric antibiotics. With culture results demonstrating ampicillin-susceptible *Enterococcus faecalis*, principles of antibiotic stewardship dictate de-escalating from broad-spectrum empiric therapy to the most targeted, effective, and safe narrow-spectrum agent available. Beta-lactams (like ampicillin or amoxicillin) are superior to vancomycin for susceptible enterococci. Because the patient is clinically stable, afebrile, and tolerating a diet, an oral agent with excellent bioavailability and urinary concentration, such as amoxicillin, is the ideal definitive therapy.

Step-by-Step Solution

1
Evaluate the patient's current clinical stability.
The patient is afebrile, hemodynamically stable, back to baseline mental status, and tolerating oral intake.
Determines that the patient is a safe candidate to step down from intravenous to oral antibiotic therapy.
2
Review the microbiological culture and susceptibility data.
The causative organism is Enterococcus faecalis, which is fully susceptible to ampicillin.
Identifies the exact pathogen to transition from empiric to definitive targeted therapy.
3
Select the most appropriate definitive antibiotic agent.
Oral amoxicillin is chosen to complete the treatment course.
Principles of antibiotic stewardship dictate selecting the narrowest spectrum, most effective, and least toxic agent available. Amoxicillin fits this perfectly for susceptible E. faecalis.

Key Concept

Antibiotic de-escalation and stewardship for fully susceptible isolates
Question 138Question →

A 71-year-old male is currently on the medical ward receiving treatment for a severe skin and soft tissue infection complicated by bloodstream invasion. He was admitted 72 hours ago with marked swelling, warmth, and purulence of his left forearm following a minor abrasion. At the time of admission, he was febrile and hypotensive, prompting the initiation of broad-spectrum coverage with intravenous vancomycin and cefepime. He has since hemodynamically stabilized and is now afebrile. The microbiology laboratory reports that both sets of blood cultures obtained at admission are positive for Staphylococcus aureus. Susceptibility testing reveals the organism is susceptible to oxacillin, cefazolin, clindamycin, and vancomycin, but resistant to penicillin. Which of the following is the most appropriate modification to his antimicrobial regimen?

Show answer & explanation

Answer: Change the regimen to intravenous cefazolin.

Answer

Change the regimen to intravenous cefazolin.
The patient's blood cultures are positive for methicillin-susceptible Staphylococcus aureus (MSSA). The current standard of care for MSSA bacteremia involves targeted intravenous therapy with a narrow-spectrum beta-lactam agent, such as a first-generation cephalosporin (cefazolin) or an antistaphylococcal penicillin (nafcillin, oxacillin). These agents have been shown to be clinically superior to vancomycin for MSSA infections, leading to faster clearance of bacteremia and improved clinical outcomes. Therefore, applying the principles of antimicrobial stewardship, the most appropriate next step is to discontinue the overly broad-spectrum empiric regimen (vancomycin and cefepime) and transition to definitive therapy with intravenous cefazolin.

Step-by-Step Solution

1
Identify the infecting organism and its resistance profile from the blood culture results.
The organism is methicillin-susceptible Staphylococcus aureus (MSSA).
Determining the specific pathogen and susceptibilities is required to narrow empiric antibiotic therapy appropriately.
2
Evaluate the current empiric antibiotic regimen against the targeted pathogen.
The patient is on vancomycin and cefepime, which are too broad and not the optimal targeted therapy for MSSA.
Prolonged use of broad-spectrum agents promotes resistance, and vancomycin is clinically inferior to anti-staphylococcal beta-lactams for MSSA.
3
Select the most appropriate definitive therapy for MSSA bacteremia.
Intravenous cefazolin is chosen as it provides targeted, superior bactericidal activity against MSSA.
Antimicrobial stewardship guidelines strongly recommend de-escalating to narrow-spectrum beta-lactams like cefazolin, oxacillin, or nafcillin for MSSA bloodstream infections.

Key Concept

Antibicrobial de-escalation for Methicillin-Susceptible Staphylococcus aureus (MSSA) bacteremia
Question 139Question →

Match the following patients presenting with malaria exposure or active infection to their most appropriate pharmacological management.

Click a left item, then click its matching right item

Items

A 35-year-old woman returns from West Africa with cyclical fever and chills. Blood smears demonstrate Plasmodium falciparum without signs of severe disease. She acquired the infection in a region with known chloroquine resistance.
A 28-year-old man experiences recurrent cyclical fevers 6 months after returning from India. Blood smears reveal Plasmodium vivax. Quantitative testing confirms his glucose-6-phosphate dehydrogenase (G6PD) levels are within normal limits.
A 42-year-old man presents with high fever, confusion, and oliguria following a trip to sub-Saharan Africa. Blood smears show Plasmodium falciparum with 8% parasitemia.
A 30-year-old pregnant woman in her first trimester is planning to travel to a chloroquine-resistant malaria endemic region and requests appropriate chemoprophylaxis.

Matches

Show answer & explanation

Answer

The scenarios match uncomplicated P. falciparum to oral artemether-lumefantrine, P. vivax to chloroquine plus primaquine, severe P. falciparum to IV artesunate, and pregnancy prophylaxis to mefloquine.
Appropriate malaria management requires identifying the infecting species (to determine the need for hypnozoite eradication), assessing clinical severity (to determine the need for intravenous versus oral therapy), understanding regional resistance patterns (to avoid chloroquine in resistant areas), and evaluating patient-specific factors (such as pregnancy or G6PD deficiency).

Step-by-Step Solution

1
Analyze the clinical scenario to determine the species of Plasmodium and the severity of the infection.
Identified uncomplicated P. falciparum, P. vivax with normal G6PD, severe P. falciparum, and a pregnant traveler needing prophylaxis.
The choice of antimalarial agent depends heavily on the infecting species, resistance patterns, disease severity, and patient-specific contraindications.
2
Match the uncomplicated P. falciparum scenario with its appropriate treatment.
Paired with oral artemether-lumefantrine or atovaquone-proguanil.
Chloroquine resistance is widespread; therefore, artemisinin-based combination therapies (ACTs) or atovaquone-proguanil are the standard of care for uncomplicated P. falciparum.
3
Match the P. vivax scenario with its appropriate treatment.
Paired with oral chloroquine followed by primaquine.
P. vivax forms dormant hypnozoites in the liver. Primaquine is required for radical cure to prevent relapse, but it can only be used after confirming normal G6PD levels to avoid severe hemolysis.
4
Match the severe P. falciparum scenario with its appropriate treatment.
Paired with intravenous artesunate followed by oral ACT.
Features of severe malaria (e.g., altered mental status, oliguria, >5% parasitemia) necessitate rapid parasitemia reduction with IV artesunate, as oral absorption may be compromised.
5
Match the pregnant traveler scenario with the appropriate chemoprophylaxis.
Paired with mefloquine.
Mefloquine is the only safe and effective chemoprophylaxis for pregnant women traveling to chloroquine-resistant areas, especially during the first trimester.

Key Concept

Pharmacological management of malaria based on species, severity, resistance patterns, and patient-specific contraindications.
Estimated Time:1m 30s
Question 140Question →

A 68-year-old woman is evaluated in the intensive care unit on hospital day 3. She was admitted with fever, left-sided flank pain, and hypotension. She was diagnosed with septic shock secondary to acute complicated pyelonephritis. Empiric therapy with intravenous piperacillin-tazobactam and aggressive fluid resuscitation were initiated. Her clinical status has improved, and vasopressor support was successfully discontinued yesterday. Today, her temperature is 37.9∘C37.9^{\circ} \text{C} (100.2∘F100.2^{\circ} \text{F}), blood pressure is 118/72 mmHg118/72 \text{ mmHg}, and heart rate is 88/min88/\text{min}. Blood and urine cultures collected on admission both grow *Escherichia coli*. The susceptibility profile of the isolate is reported as follows:

AntimicrobialSusceptibility
AmpicillinResistant
CeftriaxoneResistant
CiprofloxacinResistant
Piperacillin-tazobactamSusceptible
CefepimeSusceptible
MeropenemSusceptible
GentamicinSusceptible

Which of the following is the most appropriate next step in the pharmacologic management of this patient's infection?

Show answer & explanation

Answer: Discontinue piperacillin-tazobactam and initiate intravenous meropenem

Answer

Discontinue the current beta-lactam/beta-lactamase inhibitor combination and switch to a carbapenem.
The correct action is to escalate the patient's therapy to a carbapenem. This patient has an Escherichia coli bloodstream infection. The isolate's resistance to ceftriaxone (a third-generation cephalosporin) strongly suggests it is an extended-spectrum beta-lactamase (ESBL) producer. For invasive ESBL infections, particularly bacteremia, carbapenems (such as meropenem, imipenem, or ertapenem) are the definitive standard of care. Large randomized controlled trials (such as the MERINO trial) have demonstrated that utilizing piperacillin-tazobactam for the definitive treatment of ESBL bacteremia results in higher 30-day mortality and increased clinical failure rates compared to carbapenems, even when the isolate tests as susceptible in vitro. Therefore, despite her clinical improvement, standard antimicrobial stewardship and infectious disease guidelines require changing the regimen to a carbapenem to ensure complete clearance and prevent relapse.

Step-by-Step Solution

1
Analyze the microbiology culture and susceptibility results.
The blood culture confirms a bloodstream infection (bacteremia) with Escherichia coli.
Identifying the source and extent of infection is critical for antibiotic selection.
2
Interpret the specific resistance pattern.
The isolate is resistant to ceftriaxone (a third-generation cephalosporin), which strongly indicates the presence of an extended-spectrum beta-lactamase (ESBL) enzyme.
Ceftriaxone resistance in E. coli or Klebsiella is the primary surrogate marker for ESBL production.
3
Determine the definitive treatment standard for ESBL bacteremia.
Select a carbapenem (such as meropenem or ertapenem) over piperacillin-tazobactam, despite the latter showing in vitro susceptibility.
Clinical trial data demonstrates that carbapenems provide a significant mortality and clinical cure benefit over piperacillin-tazobactam for invasive ESBL infections.

Key Concept

For bloodstream infections caused by extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae, carbapenems are the gold standard of therapy; piperacillin-tazobactam should be avoided due to higher rates of mortality and clinical failure.
Estimated Time:2m 30s
PreviousPage 7 / 26Next
Infectious Diseases Practice Questions — USMLE Step 2 CK — Page 7 | Examkin